Vireo Growth (VREOF) Profit After Tax (2020 - 2026)

Vireo Growth (VREOF) reported Profit After Tax of -$20.3 million for Q1 2026, down 212.31% on a YoY basis from $18.1 million in Q1 2025, and little changed sequentially from -$20.4 million in Q4 2025.

Vireo Growth (VREOF) Profit After Tax (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Profit After Tax data on file, last reported at -$20.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax fell 212.31% year-over-year to -$20.3 million; the trailing twelve-month figure through Mar 2026 stood at -$81.9 million (down 194.66% YoY), and the FY2025 full-year result was -$68.1 million, down 143.2% from the prior year.
  • Profit After Tax held at -$20.3 million in Q1 2026, from -$20.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$668411.0 in Q2 2024 to a low of -$26.3 million in Q3 2025.
  • A 5-year average of -$10.8 million and a median of -$8.4 million in 2023 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax soared 90.88% in 2024 and sank 2134.26% in 2025, its largest moves.
  • Tracing VREOF's Profit After Tax over 5 years: stood at -$13.3 million in 2022, then soared by 65.5% to -$4.6 million in 2023, then sank by 242.61% to -$15.7 million in 2024, then dropped by 29.75% to -$20.4 million in 2025, then gained by 0.35% to -$20.3 million in 2026.
  • Business Quant data shows VREOF's Profit After Tax at -$20.3 million in Q1 2026, -$20.4 million in Q4 2025, and -$26.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 369.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -20.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.30 Mn
Dec 31, 2025 -20.37 Mn
Sep 30, 2025 -26.30 Mn
Jun 30, 2025 -14.93 Mn
Mar 31, 2025 -6.50 Mn
Dec 31, 2024 -15.70 Mn
Sep 30, 2024 -4.93 Mn
Jun 30, 2024 -668,411.00
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 -4.58 Mn
Sep 30, 2023 -5.23 Mn
Jun 30, 2023 -7.33 Mn
Mar 31, 2023 -8.41 Mn
Dec 31, 2022 -13.28 Mn
Sep 30, 2022 -8.42 Mn
Jun 30, 2022 -6.18 Mn
Mar 31, 2022 -14.57 Mn
Dec 31, 2021 -12.93 Mn
Sep 30, 2021 -6.87 Mn
Jun 30, 2021 -7.01 Mn